A new antibody therapy for children with medulloblastoma has shown promise during a Phase I clinical trial. The antibody, which targets a...

Tested using a new brain tissue model, the particles may be able to deliver chemotherapy drugs for glioblastoma. Read more:...

Scientists have found a novel cause of aggressive pediatric brain cancer. The St. Jude Children's Research Hospital study is the first to...

A researcher has found, through extensive data analysis, that the youngest patients with brain tumors -- those ages birth to 3 months...

Researchers hope to replicate the successes in pediatric acute lymphoblastic leukemia — among the most common pediatric cancers — by ...

Metformin, a drug commonly prescribed against diabetes, holds promise against a rare type of childhood brain tumor in laboratory...

An innovative clinical trial led by Dr. Nicholas Vitanza, a neuro-oncologist at Seattle Children’s, shows promise that delivering ...

Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness...

For decades, a deadly type of childhood cancer has eluded science’s best tools. Now doctors have made progress with an unusual treatment:...

A new combination of drugs could help to increase survival rates with fewer side effects for some children with one of the most...